Metraipolis › archive › dc_68fc2cff94c7
Does pharmacogenetic testing optimize antidepressant effectiveness in major depressive disorder? Data from a double-blind randomized controlled trial in a… — Europe PMC PMID:41277612
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41277612
- DOI
- 10.1192/j.eurpsy.2025.10132
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T07:33:55.309Z
- SHA-256 of the archived text
cef28f9cda69b3d5a8ce482ca7fd8031207e14a108cc6bc3c936f6ecb8698e3f- Stable URL of this page
https://metraipolis.com/documento/dc_68fc2cff94c7
How to cite
Does pharmacogenetic testing optimize antidepressant effectiveness in major depressive disorder? Data from a double-blind randomized controlled trial in a… — Europe PMC PMID:41277612 — Europe PMC (en), https://europepmc.org/article/MED/41277612 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_68fc2cff94c7 (Metraipolis archive dc_68fc2cff94c7, sha256 cef28f9cda69b3d5a8ce482ca7fd8031207e14a108cc6bc3c936f6ecb8698e3f)
BibTeX
@misc{dc68fc2cff94c7,
title = {Does pharmacogenetic testing optimize antidepressant effectiveness in major depressive disorder? Data from a double-blind randomized controlled trial in a… — Europe PMC PMID:41277612},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41277612},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_68fc2cff94c7; sha256 cef28f9cda69b3d5a8ce482ca7fd8031207e14a108cc6bc3c936f6ecb8698e3f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41277612. Agents can read the archived copy with the MCP tool read_document.